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RIG-I and MDA5 are cytosolic RNA sensors that play
a critical role in innate antiviral responses. Major
advances have been made in identifying RIG-I
ligands, but our knowledge of the ligands for MDA5
remains restricted to data from transfection experi-
ments mostly using poly(I:C), a synthetic dsRNA
mimic. Here, we dissected the IFN-a/b-stimulatory
activity of different viral RNA species produced
during picornavirus infection, both by RNA transfec-
tion and in infected cells in which specific steps of
viral RNA replication were inhibited. Our results
show that the incoming genomic plus-strand RNA
does not activate MDA5, but minus-strand RNA
synthesis and production of the 7.5 kbp replicative
form trigger a strong IFN-a/b response. IFN-a/b
production does not rely on plus-strand RNA syn-
thesis and thus generation of the partially double-
stranded replicative intermediate. This study reports
MDA5 activation by a natural RNA ligand under phys-
iological conditions.
INTRODUCTION
RIG-I-like receptors (RLRs) are ubiquitously expressed cyto-
plasmic pathogen recognition receptors. The RLR family of pro-
teins are DExD/H box RNA helicases, and two of its members,
namely retinoic acid-inducible gene-I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5), specialize in detecting
viral RNAs in infected cells (reviewed in Kato et al., 2011). Upon
ligand recognition, RIG-I and MDA5 interact with a mitochon-
drion-anchored adaptor molecule, MAVS, which activates
kinase complexes eventually leading to the transcription of
type I interferons (IFN-a/b) and other proinflammatory cytokine
genes (Kato et al., 2011).
RIG-I and MDA5 play differential roles in virus recognition.
RIG-I recognizes most single-stranded (ss) RNA viruses investi-Cell Regated to date, including all minus-strand RNA [()RNA] viruses
(e.g., influenza virus, Sendai virus, and vesicular stomatitis virus)
and some plus-strand RNA [(+)RNA] viruses (e.g., hepatitis C
virus and Japanese encephalitis virus) (Kato et al., 2011).
MDA5 recognizes some other (+)RNA viruses, namely encepha-
lomyocarditis virus (EMCV) (Gitlin et al., 2006; Kato et al., 2006),
Theiler’s murine encephalomyelitis virus (TMEV) (Pichlmair et al.,
2009), coxsackievirus B3 (CVB3) (Wang et al., 2010)—all of
which are members of the Picornavirus family—and mouse
norovirus (McCartney et al., 2008). Other ssRNA viruses, such
as dengue virus, West Nile virus, mouse hepatitis virus, and
several paramyxoviruses, are recognized by both RIG-I and
MDA5 (Kato et al., 2011). Recognition of a double-stranded
(ds) RNA virus, reovirus, has also been shown to involve both
of these RLRs (Kato et al., 2008).
The differential recognition of viruses by RIG-I and MDA5 has
been attributed to their distinct preferences for RNA ligands.
RIG-I can be activated by 50-triphosphate (ppp)-containing
RNAs as well as short (<2 kbp) dsRNAs (Kato et al., 2011). The
ligand specificity of RIG-I provides an explanation for how it
differentiates viral RNAs from cellular RNAs. Many RNA viruses
carry genomes that contain 50ppp or produce 50ppp-containing
RNAs during their replication cycle in the cytoplasm of infected
cells, whereas cytoplasmic cellular RNAs generally lack 50ppp.
The ligands of MDA5 are as yet poorly defined. MDA5 is
activated by transfection of a long (>2 kbp), synthetic dsRNA
analog of artificial sequence, namely polyinosinic:polycytidylic
[poly(I:C)]. Additionally, transfection-based experiments showed
that the L segments of the reovirus genome (3.9 kbp dsRNAs)
induce an IFN-b response that is partially dependent on MDA5
(Kato et al., 2006). Based on these findings, it is believed that
MDA5 recognizes long dsRNAs, which would be intrinsically
‘‘nonself.’’ However, little is known about the identities and
characteristics of physiological ligands ofMDA5 in infected cells.
Many (+)RNA viruses, including picornaviruses, produce
dsRNAs during infection. Picornaviridae is a large, highly diverse
family of human and animal viruses, includingmany pathogens of
great medical and/or economical significance. The picornavirus
genome is a 7.5–8.5 kb ssRNA molecule that harbors a single
open reading frame flanked by structured 50 and 30 nontranslatedports 2, 1187–1196, November 29, 2012 ª2012 The Authors 1187
regions and a poly(A) tail at the 30 end. The 50 terminus contains
a small (20–24 aa) viral peptide, VPg, linked via an unusual
tyrosine-RNA phosphodiester bond. Upon virus entry and
uncoating, the virion RNA (vRNA) is released into the cytoplasm
where it is directly translated. Viral RNA templates used for
protein synthesis no longer contain VPg due to the activity of
a yet unknown cellular enzyme (further referred to as unlinkase)
(Rozovics et al., 2011). The viral polyprotein is proteolytically
processed to release the viral proteins that engage in genomic
RNA replication. During this complex process, several species
of viral RNAs with unique features are generated (Figure 2A).
First, the viral genomic ssRNA is transcribed into a complemen-
tary ()RNA by the virally encoded RNA-dependent RNA poly-
merase using VPg as primer, yielding a 7.5 kbp dsRNA named
the replicative form (RF). The ()RNA is subsequently used as
a template for VPg-primed synthesis of large amounts of new
(+)RNAs, which are identical to vRNA. Newly synthesized (+)
RNAs either enter a new cycle of translation and RNA replica-
tion or are encapsidated to form new virion particles. During the
process of (+)RNA synthesis, a partially ds replicative interme-
diate (RI)—consisting of multiple incomplete (+)RNAs undergo-
ing active transcription along the full-length ()RNA—is formed.
It is generally assumed that viral dsRNAs produced in cells
infected with picornaviruses, as well as other (+)RNA viruses,
activate MDA5. However, experimental evidence supporting
such a hypothesis is lacking. In this study, we sought to identify
physiological ligand(s) of MDA5 by studying the recognition of
distinct picornavirus RNA species in transfected cells as well
as during infection. Here, we identify a naturally occurring RNA
from infected cells, the picornavirus RF, as a potent and specific
activator of MDA5 during infection.
RESULTS
MDA5 Recognizes Viruses from Various Picornavirus
Genera
The Picornavirus family contains hundreds of highly diverse
members that are subcategorized in 12 genera. Based on the
observation that MDA5 recognizes EMCV and TMEV, both
members of the Cardiovirus genus, and CVB3, an Enterovirus
(Kato et al., 2011), it is generally assumed that all picornaviruses
are recognized by MDA5, but experimental proof for this is lack-
ing. Here, we set out to investigate the role of RLRs in the
recognition of representative picornaviruses from various genera
using wild-type (WT) and RIG-I/, MDA5/, or MAVS/
mouse embryonic fibroblasts (MEFs). To bypass the requirement
for specific entry receptors, we introduced vRNAs into the cyto-
plasm by transfection rather than infection. Figure 1A shows
IFN-b responses in WT and knockout MEFs triggered by trans-
fection of vRNA of WTmengovirus (a strain of EMCV) or infection
of a mutant mengovirus (mengo-Zn). This virus generates high
levels of IFN-b because its IFN antagonist has been compro-
mised (Hato et al., 2007). Both methods resulted in a MDA5-
and MAVS-dependent, but RIG-I-independent, IFN-b induction,
demonstrating the suitability of the transfection method to iden-
tify the RLR(s) responsible for detecting picornaviruses.
Using this vRNA transfection assay, we studied recognition of
members of three human Enterovirus species. In addition, we1188 Cell Reports 2, 1187–1196, November 29, 2012 ª2012 The Autincluded Saffold virus (a recently identified human Cardiovirus),
human parechovirus (Parechovirus genus), and equine rhinitis
A virus (a member of the Aphthovirus genus that also includes
foot-and-mouth disease virus). Infectious viruses were produced
upon transfection of all vRNAs, indicating efficient RNA replica-
tion in MEFs (data not shown). Replication of all viruses induced
an MDA5- and MAVS-dependent, but RIG-I-independent, IFN-b
response (Figures 1B and 1C). These data provide experimental
evidence that a broad spectrum of picornaviruses is indeed
recognized by MDA5.
Two other cellular proteins, namely PKR and RNaseL, have
also been implicated in recognition of some viruses (Kato et al.,
2011). However, we found no difference in IFN-a/b responses
to mengo-Zn in cells deficient in RNaseL or PKR (Figure S1),
arguing against a major role of these proteins in detecting
picornavirus RNA (see Extended Results and Discussion).
Enrichment of ssRNA and dsRNA Fractions from
Picornavirus-Infected Cells
To gain more insight into the identity of the RNA species de-
tected by MDA5 in picornavirus-infected cells, we separately
enriched for ssRNAs and dsRNAs by LiCl differential pre-
cipitation from mock- and CVB3-infected HeLa cells (Fig-
ure 2B). The ssRNA pool of infected cells contained one
additional RNA species of the same electrophoretic mobility
as purified CVB3 vRNA (Figure 2C), suggesting that it repre-
sents viral genomic ssRNA. Although partially ds, the viral RI
is known to precipitate by 2M LiCl (Richards et al., 1984), the
same condition used here to prepare ssRNA fractions. How-
ever, the amount of RI is most likely too low to be detected
on gel. The dsRNA pool of CVB3-infected cells contained an
RNA species of approximately 7.5 kbp that was absent in the
dsRNA pool of mock-infected cells (Figure 2B). Both the viral
ssRNA and dsRNA bands were absent in HeLa cells infected
with CVB3 in the presence of GuHCl (Figure 2B), a well-known
inhibitor of enterovirus ()RNA synthesis (Barton and Flanegan,
1997) (Figures 2D and S2), demonstrating that these RNAs were
of viral origin.
The Picornavirus 7.5 kbp RF Is a Potent MDA5 Ligand
upon Transfection
The dsRNA fraction from CVB3-infected cells (Figure 2B) was
transfected into MEFs and IFN-b mRNA levels were measured
at 2 hr posttransfection (hr.p.t.), a time point preceding RNA
replication (Figure S2), thereby excluding the possible role of
other, newly produced viral RNA species. The dsRNA fraction
triggered a MDA5- and MAVS-dependent IFN-b response (Fig-
ure 3A). We next set out to identify the IFN-stimulatory RNA
species in this fraction. In the dsRNA fractions, we observed
two bands on gel; an infection-specific, 7.5 kbp species, and
a larger fragment that was present in both mock- and CVB3-
infected samples. To determine the nature of the higher band,
we treated the dsRNA fractions with nucleases specific for
ssRNA (RNase A), dsRNA (RNase III), and DNA. The nonspecific
larger band was completely digested upon DNase treatment,
indicating that it was DNA (Figure 3B). The 7.5 kbp CVB3 RF
was specifically digested by RNase III, confirming that this is
a dsRNA molecule (Figure 3B).hors
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Figure 1. MDA5 Recognizes Picornaviruses across Various Genera
(A) MEFs of indicated genotypes were either infected with mengo-Zn (MOI 50) or transfected with virion RNA (vRNA) from WT mengovirus. IFN-b promoter
activation at 8 hr.p.t. was determined by an IFN reporter assay.
(B) MEFs of indicated genotypes were transfected with vRNAs from three human enteroviruses (HEVs), namely enterovirus 71, coxsackievirus B3, or
coxsackievirus A21, a close relative to poliovirus. IFN-b promoter activation at 8 hr.p.t. was determined by IFN reporter assay.
(C) Same assay as (B) using vRNAs from Saffold virus 3, human parechovirus 1, and equine rhinitis A virus. Data presented as mean ± SD.
See also Figure S1.Next, we examined the ability of purified CVB3 RF to activate
MDA5. When gel-extracted and transfected into MEFs, the RF,
but not the DNAmolecule, induced high levels of IFN-b transcrip-
tion in an MDA5- andMAVS-specific manner (Figure 3C). Similar
experiments were performed with nucleic acids extracted from
cells infected with mengovirus. The dsRNA fraction frommengo-
virus-infected cells appeared indistinguishable on gel from that
from CVB3-infected cells (Figure 3D), and the gel-purified
mengovirus RF also proved to be a potent MDA5 agonist (Fig-
ure 3E). These data show that the RF of prototype members of
at least two genera of picornaviruses can specifically and
potently induce an MDA5-dependent IFN-a/b response.
To investigate whether the RF can directly activate MDA5, we
performed in vitro ATPase assays where recombinant MDA5Cell Rewas incubated with gel-purified RF or the nonspecific DNA
band in the presence of ATP. ATP hydrolysis was followed at
different time points by measuring free phosphate. CVB3 RF
induced high levels of MDA5 ATPase activity—hydrolyzing
nearly 150 mMATP in 60min—while the DNAband did not induce
any ATP hydrolysis during this time period (Figure 3F). These
results are in line with our transfection data (Figures 3C
and 3E) and confirm that RF can be directly recognized by
MDA5 and potently induce its activation.
Picornavirus ssRNAs Do Not Activate MDA5
We also tested the ssRNA fraction from infected cells (Figure 2B)
for its IFN-b-stimulatory activity. To our surprise, transfection of
this fraction also led to an MDA5- and MAVS-dependent IFN-bports 2, 1187–1196, November 29, 2012 ª2012 The Authors 1189
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Figure 2. Enrichment of ssRNA and dsRNA
Fractions of CVB3-Infected Cells
(A) Viral RNA species produced during picorna-
virus infection. RF, replicative form. RI, replica-
tion intermediate. Purple line, (+)RNA; blue line,
()RNA; orange circle, VPg.
(B) HeLa cells were infected with CVB3 in the
absence or presence of replication inhibitor GuHCl
(2 mM) for 5 hr and total RNA was extracted.
ssRNA and dsRNA fractions were separated by
LiCl differential precipitation and examined on
agarose gel. Note that the ssRNA fraction was
diluted 400-fold relative to the dsRNA fraction to
load comparable amounts of RNAs. M, dsDNA
marker with indicated size in kbp; closed arrow,
viral ssRNA; arrowhead, viral dsRNA; asterisk,
unknown bands.
(C) vRNA purified from pelleted virus particles was
visualized on agarose gel next to the same DNA
marker as used in (A).
(D) HeLa cells were infected with CVB3 (MOI 100)
in the absence or presence of GuHCl (2 mM) for
2.5 hr and the dsRNA fraction was purified from
total RNA extract by LiCl precipitation and exam-
ined on gel. M, dsDNAmarker; arrow, viral dsRNA;
asterisk, unknown bands.
See also Figure S2.response (Figure 4A). However, subsequent nuclease digestion
experiment revealed that the IFN-b-stimulatory activity is sensi-
tive to RNase III (dsRNA-specific) treatment, but not RNase A
(ssRNA-specific) (Figures 4B and 4C). Indeed, after removal of
rRNAs—the most abundant RNA species present in the ssRNA
fractions—we observed a RNA species on gel that is specifically
present in infected cells and has the same electrophoretic
mobility as the RF band found in the dsRNA fraction from in-
fected cells (Figure S3A). These results suggest that residue
amounts of RF are still present in our ssRNA fraction prepara-
tions, and the RF, but not viral ssRNAs, is responsible for the
observed IFN-b induction upon transfection of this fraction. In
line with this conclusion, we found that VPg-containing vRNA
(Figures 4D and 4E), VPg-unlinked viral mRNAs (Figure 4E),
and in vitro transcribed ssRNAs of viral sequence (Figures
S3B and S3C) all failed to induce any IFN-b response when puri-
fied and transfected into cells.
The viral RI was also reported to segregate in the ssRNA frac-
tion according to the LiCl precipitation method (Richards et al.,
1984). To study the effect of RI on IFN-a/b induction without
complications from RF, we attempted to remove the remaining
RF fromCVB3 ssRNA fraction by repeating the 2MLiCl precipita-
tion procedure. However, even after two additional rounds of
precipitation, we did not observe significant loss of RF from the
CVB3 ssRNA fraction, nor did we observe a reduced IFN-b
response upon transfection (data not shown). Hence, we were
unable to determine whether RI also exerts IFN-inducing activity.1190 Cell Reports 2, 1187–1196, November 29, 2012 ª2012 The AuthorsFormation of Viral RF, but Not RI, Is
Required for IFN-b Induction in
Infected Cells
Our results indicated that the picornavirus
RF, and possibly also the RI, is a potentMDA5 activator when delivered into the cytoplasm by lipid-
based transfection. However, the amount of RF/RI and their
accessibility to MDA5 may differ greatly from the situation in
infected cells, where viral RNA is covered with replication
enzymes and localized in virus-induced, membrane-associated
replication organelles (reviewed in Belov and van Kuppeveld,
2012). Therefore, we set out to dissect the IFN-stimulatory abil-
ities of different viral RNAs produced in cells infected with
mengo-Zn, which induces strong IFN-b responses.
We first generated a comprehensive profile of the kinetics of
viral RNA replication as well as host IFN-b response to mengo-
Zn in HeLa cells by measuring viral RNA and IFN-bmRNA levels
by real-time quantitative PCR (qPCR) every hour up until 10 hr
postinfection (hr.p.i.) (Figure 5A). Viral RNA level remained at
input levels in the first 3 hr of infection, then rapidly increased
(i.e., active viral RNA replication) to reach a maximum at
6 hr.p.i., and stabilized at this level through 10 hr p.i. The host
IFN-b response showed a slight delay as IFN-b mRNA levels in
infected cells remained at background levels through the first
6 hr, then started to increase from 7 hr.p.i., and reached their
maximum at 8–9 hr p.i.
To study the separate contribution of viral ssRNA and dsRNA
in inducing IFN-a/b response during infection, we employed
inhibitors ofmengovirus replication, cycloheximide (CHX) and di-
pyridamole (DIP) (Figure 5B), which affect viral replication at
different stages. CHX prevents protein synthesis and thereby
RNA replication. DIP has little effect on ()RNA synthesis but
strongly inhibits (+)RNA synthesis in cell-free extract (Fata-
Hartley and Palmenberg, 2005). Indeed, ()RNAs were detected
in cells infected in the presence of DIP, but not CHX, using
a strand-specific PCR (Figure 5C). The finding that the signal ob-
tained from DIP-treated cells was lower than that from no-drug-
treated cells likely reflects a reduced amount of ()RNA as DIP
only allows ()RNA synthesis from incoming genomic (+)RNA,
whereas in the absence of DIP newly synthesized (+)RNAs can
enter a new round of RNA replication, and therefore lead to the
production of more RF.
To determine the IFN-b response to different viral RNA species
formed in infected cells, we used DIP and CHX in a time-of-drug-
addition experiment. HeLa cells were infected with mengo-Zn,
and DIP or CHX was added to cells at the indicated times (Fig-
ure 5D). Cells were incubated until 12 hr.p.i., harvested, and viral
RNA and IFN-b mRNA levels were determined by real-time
qPCR. As shown in Figure 5D, both DIP and CHX were effective
in inhibiting viral RNA replication when added at early stages
(0–2 hr.p.i.) of infection. Later addition of the drugs resulted in
partial, and eventually loss, of effect on RNA replication.
Under conditions where CHX and DIP completely inhibited
viral RNA replication (i.e., added at 0–2 hr.p.i., Figure 5D), no
IFN-b induction was detected in CHX-treated cells, whereas
a 100-fold, MDA5-dependent (Figure S4) induction of IFN-b
mRNA level was observed in DIP-treated cells. Additionally,
when CHX or DIP was added at 3 hr.p.i., a maximal IFN-b
response was observed in DIP-treated cells, but virtually no
IFN-bwas induced in the CHX-treated cells (Figure 5D). Analysis
of viral RNA levels indicate that only a few new (+)RNAs had been
made because addition of either CHX or DIP at this time point led
to only a slight increase in viral RNA copy number at 12 hr.p.i.
These newly synthesized (+)RNAs could serve as template to
make additional RFs in the DIP-treated cells, but not in the
CHX-treated cells, and result in the increase of IFN-b induction
observed at 3 hr p.i. It is theoretically possible that the observed
differences in IFN-b levels in CHX- and DIP-treated cells were
due to nonspecific blockade or stimulation of the RLR signaling
pathway by CHX or DIP, respectively. However, this is unlikely
because these drugs had no such effects on poly(I:C)-induced
IFN-b responses (Figure S5).
In the experiment described above, the incoming vRNA alone
(i.e., in the presence of CHX) induced no IFN-b response. To
exclude that the amount of incoming vRNA at the used MOI
was too low to induce a detectable IFN-b mRNA upregulation,
we increased the infection dose from MOI 10 to 1,000. This
resulted in increased levels of IFN-b in no-drug- and DIP-treated
samples, but in CHX-treated cells the IFN-b level remained
undetectable (Figure 5E). This result clearly shows that the
incoming vRNA, even when present at very high quantities,
does not activate MDA5. Taken together, our results demon-
strate that ()RNA synthesis (i.e., formation of RF), but not (+)
RNA synthesis (i.e., formation of RI), is required for achieving
high levels of IFN-a/b induction.
Termini and Length Dependency of MDA5 Activation
by Long dsRNAs
We next investigated whether the termini of picornavirus RF are
important for MDA5 activation. The viral RF contains a VPgCell Repeptide at the 50 end of the ()RNA, but not at the 50 end of the
(+)RNA, because of the activity of the unlinking enzyme. Further-
more, the RF contains a large unpaired poly(A) tail at the 30 end
of the (+)RNA (van Ooij et al., 2006). To investigate whether
these features are important for MDA5 activation, we produced
CVB3 and mengovirus dsRNAs with 50ppp and perfectly paired
termini by in vitro transcription (ivt dsRNA) and compared
them with viral RF purified from infected cells for their ability to
activate MDA5. Strikingly, all dsRNAs triggered a similar IFN-b
response upon transfection into RIG-I/ MEFs (Figure 5F).
Additionally, CVB3 ivt dsRNA activated MDA5 to a similar extent
as CVB3 RF in our in vitro ATPase assay (Figure 3F). Thus, the
recognition of long dsRNAs by MDA5 is likely independent of
the termini of the RNA molecule.
Lastly, we investigated whether MDA5 activation by long
dsRNAs is length dependent as proposed by Kato et al., who
showed that only long polyIC molecules (>2 kb) are efficiently
recognized by MDA5 (Kato et al., 2008). To this end we gener-
ated ivt dsRNAs of various lengths (0.1–7.4 kbp) and determined
IFN-b activation levels by real-time qPCR upon transfection of
different amounts of these fragments. At relatively low quantities
(10 ng), ivt dsRNAs shorter than 2.4 kbp induced only low levels
of IFN-b mRNA. However, when larger amounts of dsRNA
(100 ng) were transfected, smaller dsRNAs were also able to
trigger an IFN-b response (Figure 5G), indicating that there
may not be a strict length cut-off value for MDA5 ligands.
DISCUSSION
Since the initial discovery of RLRs, significant progress has
been made in identifying ligands for RIG-I, but the identity and
molecular characteristics of viral MDA5 ligands remain largely
unknown. Based on transfection experiments using poly(I:C),
MDA5 is believed to recognize long dsRNAs. However, viral
ssRNAs should not be excluded because base-paired regions
in ssRNAs, as those in the picornavirus genomic RNA, could
potentially be sufficient for MDA5 recognition. Furthermore,
a virally encoded peptide, VPg, is covalently attached to the
50 terminus of picornavirus RNAs via a unique tyrosine-RNA
bond, providing a potential ‘‘nonself’’ signature at the 50 end.
Bearing this information in mind, we followed an unbiased
approach to determine the IFN-stimulatory activities of different
viral RNA species produced in picornavirus-infected cells.
The viral dsRNA, RF, has been assumed to be the MDA5
ligand produced by picornaviruses based on the fact that all
known activators of MDA5 are dsRNAs (mimics). Here, we
provide experimental evidence that purified picornavirus RF
can not only induce an MDA5-dependent IFN-a/b response
upon transfection, but also directly bind to, and activate,
MDA5 in vitro. Viral ssRNAs, on the other hand, proved poor
MDA5 stimuli. Neither vRNA (VPg-containing) nor viral mRNA
(VPg-lacking) induced an IFN-b response when transfected
into cells. This is in line with the observation that the full-length
EMCV RNA failed to activate MDA5 ATPase activity in vitro
(Peisley et al., 2011). Although we could not test IFN-stimulatory
activity of purified RI, this molecule does not seem to play
a crucial role in inducing IFN-a/b because treatment of the
CVB3 ssRNA fraction with RNase A did not affect its ability toports 2, 1187–1196, November 29, 2012 ª2012 The Authors 1191
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Figure 3. Picornavirus RF Is a Potent MDA5 Agonist
(A) dsRNA fractions from mock- or CVB3-infected HeLa cells were transfected-into MEFs of indicated genotypes, and IFN-b mRNA level at 2 hr.p.t. was
measured by real-time qPCR. Data presented as mean ± SD.
(B) dsRNA fractions (dsPool) of mock- and CVB3-infected cells were treated with 10 ng/ml RNase A, 10 mU RNase III, or 10 mU DNase I at 37C for 15 min, and
analyzed on agarose gel.
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induce IFN-a/b. This observation also speaks against the
hypothesis that other (viral) ssRNAs—which might have been
produced by the action of cellular RNases like RNaseL—may
be recognized by MDA5.
Collectively, our transfection experiments clearly identify the
RF as an MDA5 agonist. Previously, Pichlmair and colleagues
identified two virus-induced RNA species in their total RNA
extract from EMCV-infected cells: one dsRNA of approximately
12 kbp and one high-molecular-weight RNA (HMW-RNA) that
consisted of both ssRNAs and dsRNAs (Pichlmair et al., 2009).
The HMW-RNA, but not the 12 kbp dsRNA, was found to be
IFN-a/b stimulatory upon transfection. We never observed either
of these RNAs in our total RNA extracts or the fractionated
RNA preparations. The identity of the HMW-RNA and the IFN-
stimulatory element(s) within their mixed RNA population
remains unclear.
Although transfection may be a convenient method to study
aspects of MDA5 ligand recognition, it may not faithfully re-
capitulate physiological conditions for several reasons. First,
transfection delivers large amounts of viral RNA directly into
the cytoplasm at once. This is different from the RNA release
process during infectious entry as well as the gradual accumula-
tion of viral RNAs during virus replication. Second, purified, and
therefore ‘‘naked,’’ RNAs are transfected into cells whereas viral
RNAs are heavily coated with viral and host factors during infec-
tion. Third, (+)RNA viruses induce the formation of membranous
replication organelles, which may restrict access of MDA5 to
replication intermediates such as RF and RI. To gain insight
into MDA5 activation in a more physiologically relevant situation,
we studied MDA5 activation in infected cells. Our data show that
the incoming genomic ssRNA alone cannot induce any detect-
able IFN-b response even when large amounts were delivered
by high MOI infection. When ()RNA synthesis (i.e., formation
of RF) was permitted but (+)RNA synthesis (i.e., formation of RI)
was inhibited, a significant upregulation of IFN-b mRNA was
observed. These data further support the idea that picornavirus
RF is the essential MDA5 agonist in the course of infection. Of
note, a much higher IFN-b response was observed when RNA
replication was allowed to proceed fully (i.e., in the absence
of inhibitor). Although this finding may be interpreted as that
RIs also activate MDA5, this increase can be attributed, at least
partly, to the increased amount of RF produced from newly
synthesized (+)RNAs that enter new rounds of RNA replication.
Recently, Zu¨st et al. suggested that MDA5may also recognize
RNA molecules with a ‘‘nonself’’ 50 termini, as a mutant coro-
navirus deficient in fully capping its mRNAs activated MDA5 in
infected cells (Zu¨st et al., 2011). Because picornavirus RF
harbors distinctive termini, we investigated whether this terminal(C) DNA and RF bands observed in CVB3 dsRNA fraction were gel purified and an
and the gel-purified RNAs (10, 2, or 0.4 ng/well) were transfected intoWT, RIG-I/
induction was determined by real-time qPCR at 8 hr.p.t.
(D) dsRNA fractions of mock-, CVB3-, or mengovirus-infected cells were analyze
(E) DNA and RF bands frommengovirus dsRNA fraction were gel purified and tran
at 8 hr.p.t. was measured by real-time qPCR.
(F) Gel-purified RF and DNA bands from CVB3 dsRNA fraction, as well as a in vitro
with recombinant MDA5 (0.3 mM) at 37C in the presence of 2mM ATP, and free
started. M, dsDNA marker with indicated size in kbp. Bands number 1 and 2 on
mean ± SD.
Cell Recomposition of the RF is essential for MDA5 activation. Chang-
ing the physiological terminal groups of RF into 50ppp and
fully complemented 30 end did not change its ability to in-
duce IFN-b upregulation. Other features such as secondary
structures are common requirements for ligand recognition;
however, the picornavirus RF is not known to contain distinct
higher structures. Thus, it is likely that the long ds nature of the
RF, and not its unique termini, renders this RNA a potent
MDA5 activator.
We also investigated the length dependency of MDA5 ligand
recognition because it has been suggested that only dsRNAs
longer than 2 kbp can induce MDA5 activation (Kato et al.,
2008). We tested dsRNAs of viral sequence in vitro that span
a wide range of sizes (0.1–7.4 kbp), and found that although
longer dsRNAs activate MDA5 more efficiently when provided
at equal mass, short dsRNAs could also induce some levels of
MDA5 activation when present in large quantities. These data
suggest that MDA5 may not require its substrate to be longer
than a strict cut-off size. In line with this, others have demon-
strated efficient activation of MDA5 ATPase activity by dsRNAs
as short as 112 bp (Peisley et al., 2011). Authors of this paper
also showed that MDA5 ATPase activity, which is triggered by
ligand binding, induces disassembly of MDA5 from the RNA
ligand, the rate of which is inversely related to the length of the
bound RNA molecule (Peisley et al., 2011). This provides some
molecular explanation why longer dsRNAs are more efficient in
activating MDA5 than shorter ones.
While this paper was in preparation, another study reported
that enterovirus dsRNAs, but not ssRNAs, can activate MDA5-
dependent IFN-b responses upon transfection (Triantafilou
et al., 2012). Also shown in this study is colocalization of MDA5
with dsRNA in enterovirus-infected cells. Although not providing
evidence of direct binding or functional activation, these data
nicely show that MDA5 and viral dsRNA can be found in physical
vicinity, and therefore support our results that the RF can
activate MDA5 in infected cells.
Collectively, our data suggest that the 7.5 kbp RF of picor-
naviruses is a highly potent MDA5 activator and is directly
recognized by MDA5. Moreover, this study shows that manipu-
lating specific steps of virus replication is a powerful approach to
study recognition of specific viral RNA species by RLRs under
physiological conditions.EXPERIMENTAL PROCEDURES
Cells, Viruses, Infectious cDNA Clones, and Reagents
MEFs and HeLa cells were maintained in DMEM supplemented with 10% FBS
and cyproxin (1 mg/ml). Viruses are described in Extended Experimentalalyzed on agarose gel. CVB3 dsRNA fraction (10 ng per well in 24-well format),
, MDA5/, or MAVS/MEFs in the presence of CHX (10 mg/ml). IFN-bmRNA
d on agarose gel.
sfected into RIG-I/MEFs in the presence of CHX (10 mg/ml). IFN-b response
transcribed dsRNA of CVB3 sequence (ivt dsRNA) (0.3 mg/ml), were incubated
Pi was measured using Green Reagent at 0, 30, and 60 min after reaction was
gel corresponds to the samples used in RNA transfection. Data presented as
ports 2, 1187–1196, November 29, 2012 ª2012 The Authors 1193
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Figure 4. ssRNAs from CVB3-Infected Cells Do Not Activate MDA5
(A) ssRNA fraction frommock- or CVB3-infected HeLa cells were transfected into MEFs of indicated genotypes, and IFN-bmRNA level at 2 hr.p.t. was measured
by real-time qPCR. Data presented as mean ± SD.
(B) ssRNA fractions (ssPools) of mock- and CVB3-infected cells were treated with 10 ng/ml RNase A, 10 mU RNase III, or 10 mU DNase I at 37C for 15 min.
Resulting RNA samples equivalent to 500 ng starting material were transfected into approximately 200,000 MAVS+/+ MEFs and IFN-b mRNA induction was
determined by real-time qPCR at 8 hr.p.t. Data presented as mean ± SD.
(C) The same samples as in (B) were analyzed on agarose gel.
(D) CVB3 vRNAwas isolated from pelleted viral particles. Indicated amounts of vRNAwere transfected into RIG-I/MEFs in the presence of CHX (10 mg/ml), and
IFN-b mRNA induction was determined by real-time qPCR at 8 hr.p.t.. Data presented as mean ± SD.
(E) Indicated amounts of mock-treated or unlinkase-treated poliovirus vRNAs were transfected into RIG-I/MEFs in the presence of CHX (10 mg/ml). Total RNA
was extracted at 8 hr.p.t. and IFN-b mRNA induction was determined by real-time qPCR. Data presented as mean ± SD.
See also Figure S3.Procedures. Infectious cDNA clones p53CB3/T7 (Wessels et al., 2005) and
pM16.1 (Hato et al., 2007) were used to produce in vitro transcribed RNAs
with CVB3 or mengovirus sequences, respectively. CHX and DIP were
purchased from Sigma-Aldrich, and RNase A, RNase III, and DNase I from
Ambion.
Isolation of Viral RNA from Virions
Cells were infected with virus and grown until cytopathic effect was complete.
This lysate was subjected to three freeze-thaw cycles, cleared, and centri-1194 Cell Reports 2, 1187–1196, November 29, 2012 ª2012 The Autfuged at 25,000 rpm for 6 hr in an SW28 rotor at 4C. The virus pellet was sus-
pended in either TRIzol reagent (Invitrogen) or the lysis buffer of GenElute
mammalian total RNA Miniprep Kit (Sigma-Aldrich), and RNA was isolated
according to the manufacturers’ instructions.
Isolation of ssRNA and dsRNA Fractions from Control and Infected
Cells
Total RNA was isolated using TRIzol (Invitrogen) according to manufacturer’s
protocol. LiCl was added to the total RNA extract to an end concentration ofhors
AB C
D
E
F G
Figure 5. Viral RNA Recognition in Infected
Cells and Characterization of Determinant
for MDA5 Activation in RF
(A) HeLa cells were infected with mengo-Zn (MOI
10) and samples were taken every hour post-
infection. Total RNA was extracted and viral RNA
and host IFN-bmRNA levels were assayed by real-
time qPCR.
(B) Cells were infected with mengo-Zn in the
absence or presence of DIP (100 mM). Production
of infectious particles was determined by end-
point titration on BHK-21 cells.
(C) HeLa cells were mock-infected or infected with
mengo-Zn (MOI 20) in the absence or presence of
CHX (10 mg/ml) or DIP (100 mM) and total RNA was
extracted at 6 hr.p.i. dsRNA fraction was purified
by LiCl precipitation and subjected to RT-PCR
using primers specific to viral () RNA.
(D) HeLa cells were infected withmengo-Zn atMOI
10. CHX (10 mg/ml) or DIP (100 mM) was added to
infected cells either at time of infection or at indi-
cated times postinfection. All samples were
harvested at 12 hr.p.i. Total RNA was extracted
and viral RNA and host IFN-b mRNA levels were
analyzed by real-time qPCR.
(E) HeLa cells were infected with mengo-Zn at
indicated MOI’s in the absence or presence of
CHX (10 mg/ml) or DIP (100 mM). Total RNA was
extracted at 10 hr.p.i. and viral RNA and host IFN-b
mRNA levels were measured by real-time qPCR.
Data presented as mean ± SD.
(F) RFs of CVB3 and mengovirus as well as in vitro
transcribed dsRNAs of viral sequences were
transfected into RIG-I/ MEFs in the presence of
CHX (10 mg/ml) at indicated amounts per well in
24-well format. IFN-b mRNA levels were deter-
mined at 8 hr.p.t. by real-time qPCR. Data pre-
sented as mean ± SD.
(G) polyIC or in vitro transcribed dsRNAs of indi-
cated length were transfected into RIG-I/ MEFs
in the presence of CHX (10 mg/ml) at indicated
amounts. IFN-b mRNA levels were determined at
8 hr.p.t. by real-time qPCR. Data presented as
mean ± SD.
See also Figures S4 and S5.2 M. This was incubated at 4C for 2–16 hr, and ssRNAs were precipitated
by centrifugation at 16,000 3 g for 30 min at 4C. The supernatant was sub-
jected to ethanol precipitate in the presence of 0.8M LiCl to precipitate
dsRNAs. RNA pellets were washed with 75% ethanol, air-dried, and dissolved
in RNase-free water.
IFN reporter assay and real-time qPCR analysis were carried out as
described previously (Hato et al., 2007).
Preparation of Full-Length IVT RNAs
ssRNAs and dsRNAs were transcribed using Riboprobe in vitro transcription
systems (Promega) and Replicator RNAi Kit (Finnzyme), respectively, following
the manufacturers’ instructions. RNAs were treated with DNaseI and purified
prior to transfection.Cell Reports 2, 1187–1196, NoGeneration of partially purified VPg unlinkase,
isolation of 35S-methionine-labeled vRNA, and
in vitro unlinking reactions were conducted as
described previously (Rozovics et al., 2011).
In vitro MDA5 ATPase assay was performed as
described previously (Peisley et al., 2011).Ribosomal RNA removal was performed using Ribo-Zero rRNA Removal Kit
(Human.Mouse.Rat) (Epicenter RZH1046) according to the manufacturer’s
protocol.
Additional Information
More detailed descriptions of experimental procedures and materials are
provided in Extended Experimental Procedures.
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